Express Pharma

SEPTEMBER 6, 2023

To help financially weak citizens gain access to affordable healthcare, the Pradhan Mantri Jan Arogya Yojana (PMJAY) was launched in 2018, providing about 500 million Indians with a ₹5 lakh family health insurance cover that include coverage for 1,400 medical procedures as well as critical diseases like prostate cancer.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

PharmaShots

JUNE 2, 2023

Anas Batikhi: The healthcare sector, an ongoing evolving industry on its own, is simply a flowing stream of processes, revenues & valuable health outcomes. Getting this process wrong is detrimental to any revenue collections resulting from availing services to the patient.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Health and Personal Care Stores Medical Records Documentation 40

Putting Patients First Blog

JANUARY 10, 2024

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Diabetes 40

The Thyroid Pharmacist

JUNE 30, 2023

LDN was one of the first interventions that I had tried on my thyroid journey back in 2009. Luckily, even without insurance coverage, this medication is available in generic form and is very affordable, usually costing between $15 to $40 per month. It’s a process and a journey, but it’s definitely worth it.

Compounding 98

Compounding Immunity Immunization Compounding Pharmacies 98

PharmaShots

JUNE 28, 2023

In 2009, Pfizer acquired Wyeth thus seeking the rights to Enbrel. Under this agreement, Wyeth and Amgen jointly marketed and sold Enbrel to all appropriate segments in the U.S. and Canada for all approved indications other than oncology. The rights to promote Enbrel in the U.S. and Canada for oncology indications were reserved for Amgen.

Biosimilars 40

Biosimilars Insurance Coverage and Processing Dosage Compounding 40

Putting Patients First Blog

SEPTEMBER 9, 2024

As these technologies become increasingly integral to patient care, it is essential for CMS to develop clear and consistent guidelines for the payment and coverage of AI-enabled services. Providing clear guidance, technical assistance, and streamlined processes can help facilitate the adoption of this innovative care model.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40